Landmark Cars

Latest News

Battle of Galwan cast fee: How Salman Khan’s massive pay cheque compares to his co-stars

Salman Khan may have taken a pay cut for Battle of Galwan, but his remuneration for Apoorva Lakhia’s film still…

By Entertainment Desk

Entertainment

December 31, 2025 14:56 IST

Vodafone Idea's share price has jumped nearly 3.56% in intraday trade. The stock is up over 25.75% in the last 1 month. Furthermore, it is up 55.86% in 2025 so far.

Vodafone Idea gets Rs 6.78-crore GST penalty; company to challenge tax order

In its regulatory filing to the stock exchanges, Vodafone Idea said it does not agree with the order and will…

By FE Business

Business

December 31, 2025 14:50 IST

Economics in the 21st century

The crises of the 21st century demand a new economic understanding.

By Guest

Opinion

December 31, 2025 14:45 IST

silver price crash, Silver price, Silver price fall, silver rate, silver all-time high level

Silver once again slips over 6%, drops 14% from Monday’s all-time high level. Here is why

Silver has begun the week poorly, with a notable increase in price volatility.

By Sunil Dhawan

Gold Pulse

December 31, 2025 14:33 IST

140% gains Vs sharp loss: 3 reasons Silver is volatile while beating

Silver’s price swings by 140% in 2025 fuel excitement—discover 3 key reasons behind its volatility and future outlook!

By FE Business

Market

Updated: December 31, 2025 14:29 IST

JP Morgan Grasim Industries buy call 2026 Rs 3300 target

JP Morgan calls it ‘Buy One, Get Four Free’ stock — 5 reasons why it predicts 16% upside

JP Morgan sees a fresh 2026 value surge in Grasim Industries, calling it a “buy one, get four free” stock.…

By Shivangini Gupta

Market

December 31, 2025 14:22 IST

Tata Steel JSW Steel RITES Bharat Forge top midday movers India

Stocks making biggest moves midday: Vodafone Idea, Tata Steel, JSW Steel, Premier Energies and more

Steel, defence, and renewable energy stocks dominated India’s final trading session of 2025. Tata Steel, RITES, and Bharat Forge led…

By Shivangini Gupta

Market

December 31, 2025 14:07 IST

2025 SBS Drama Awards: When and where to watch; nominees, hosts – all you need to know

The 2025 SBS Drama Awards will document a high-stakes competition between Lee Je Hoon, Park Hyung Sik, Han Ji Min…

By Ashima Grover

Entertainment

Updated: December 31, 2025 13:46 IST

Why has Trump Mobile delayed gold-coloured smartphone launch yet again?

The Trump Mobile was first announced as a device “built in the United States” — with a metallic golden case…

By Anwesha Mitra

US News

December 31, 2025 13:24 IST

Meet Divya Narendra: Indian-origin Harvard student who sued Mark Zuckerberg over Facebook idea

Divya Narendra is an American entrepreneur of Indian origin, renowned for co-founding HarvardConnection (later ConnectU) and his pivotal role in…

By Tech Desk

Life

December 31, 2025 13:19 IST

Related News

A Mumbai resident has alleged that a Blinkit delivery partner cancelled an order after delivering it and later demanded payment, with the situation escalating so much so that he allegedly threatened his wife and domestic help while he was away.

‘Getting threat calls at 5 am’: Blinkit customer alleges harassment over delivery dispute, tags Zomato CEO Deepinder Goyal

‘No job in Canada without…’: NRI who returned to India 1.5 years ago calls it ‘best decision’

Meta CEO Mark Zuckerberg’s $14 billion AI hire Alexandr Wang enters Forbes 40 Under 40 self-made billionaires list

Mark Zuckerberg’s Meta Superintelligence Lab goes global: Chief AI Officer Alexandr Wang announces new hiring in Singapore

Indian Govt urges vehicle owners, DL holders to update mobile number on Vahan, Sarathi portals: Here’s how

According to Legg, the disruption will be uneven across industries.

AI will end work-from-home, says Google DeepMind Co-Founder Shane Legg

Ajanta Pharma’s anti-obesity pivot: 4 reasons why Motilal Oswal sees 17% upside

Market3 hr ago

Motilal Oswal maintains a Buy rating and sets a target price of Rs 3,145 for Ajanta Pharma due to its plans for expansion and product enhancement. The company is expected to outperform the industry with its strong MR presence and shift towards a chronic-focused portfolio. The partnership with Biocon and potential earnings growth in FY27 are also seen as significant drivers.

View all shorts